8 signals · h1b_lca
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Some stress signals present but below significant thresholds.
Low-to-moderate risk signals with no major red flags in current data.
Signal data from 2 sources places Flatiron Health in the Oncology Data / EHR space at moderate workforce stress signals with low overall risk indicators.
Signals for Flatiron Health were collected from 2 sources. Aggregate signal sentiment appears broadly positive. The stress score stands at 40/100 with a risk score of 32/100. These findings are based on a limited number of signals and may not be fully representative.
What this means
Limited signals collected so far — this score may shift significantly as more data arrives.
Flatiron Health and COA Study: Community Oncology Survival Rates Outperform SEER National Benchmarks HIT Consultant
Oncology research and EHR platform.
Based on 8 signals across 1 source · snapshot 6 Sept 2026
Limited — treat this score as early-stage; more data needed.
Overall community sentiment for Flatiron Health is positive based on public signals as of 6 Sept 2026.
Limited coverage — score may shift as signals arrive.
Based on 8 signals across 1 source
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
AI-generated from public signals — may be incomplete. Based on 2 recent signals.
This summary is generated from publicly available review and signal data. It is intended as an indicative overview only and should not be used as the sole basis for employment, investment, or business decisions. Signal volume and source diversity may limit representativeness.
AI summaries are generated from public signals and may not reflect the full picture.